國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 910995      在线人数 : 964
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版
    圖書 [0/1]
    會議論文/會議摘要 [13/20]

    类别统计

    近3年内发表的文件:10(17.24%)
    含全文笔数:56(96.55%)

    文件下载次数统计
    下载大于0次:56(100.00%)
    下载大于100次:51(91.07%)
    全文下载总次数:23519(79.17%)

    最后更新时间: 2024-12-01 10:23


    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目1-50 / 58. (共2页)
    1 2 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2024-07-06 Delayed diagnosis of tuberous sclerosis complex: Unveiling low-level TSC2 mosaicism using targeted next-generation sequencing Clinical and Experimental Dermatology. 2024 Jul 06;Article in Press.
    2024-06-19 CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity Cell Death and Disease. 2024 Jun 19;15(6):Article number 434.
    2024-04 Surgical excision and radiotherapy for brain metastasis from colorectal cancer: How frailty and comorbidity indices influence outcome Kaohsiung Journal of Medical Sciences. 2024 Apr;40(4):395-403.
    2024-01-30 Neutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity Cell Death and Disease. 2024 Jan 30;15:Article number 103.
    2023-07-31 Role of SH3GLB1 in the regulation of CD133 expression in GBM cells BMC Cancer. 2023 Jul 31;23:Article number 713.
    2023-07-22 The complex role of eicosanoids in the brain: Implications for brain tumor development and therapeutic opportunities Biochimica et Biophysica Acta. Reviews on Cancer. 2023 Jul 22;1878(5):Article number 188957.
    2023-05-30 A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment American Journal of Cancer Research. 2023 May 30;13(5):1952-1969.
    2022-07-13 SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma Journal of Experimental and Clinical Cancer Research. 2022 Jul 13;41:Article number 220.
    2022-03-25 Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation Journal of Biomedical Science. 2022 Mar 25;29:Article number 21.
    2022-02-02 HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells Journal of Experimental and Clinical Cancer Research. 2022 Feb 2;41:Article number 47.
    2021-10-19 SOD2 enhancement by long-term inhibition of the pi3k pathway confers multi-drug resistance and enhanced tumor-initiating features in head and neck cancer International Journal of Molecular Sciences. 2021 Oct 19;22(20):Article number 11260.
    2021-09-28 Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells Cell Death and Disease. 2021 Sep 28;12(10):Article number 884.
    2021-06-12 Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
    2021-05-14 Transferrin modified gsh sensitive hyaluronic acid derivative micelle to deliver hsp90 inhibitors to enhance the therapeutic efficacy of brain cancers Cancers. 2021 May 14;13(10):Article number 2375.
    2021-05 A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer Gastric Cancer. 2021 May;24(3):624-639.
    2021-05 A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.] Gastric Cancer. 2021 May;24(3):640-641.
    2021-04 Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors Oncologist. 2021 Apr;26(4):e567-e579.
    2021-03-08 Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma Journal of Biomedical Science. 2021 Mar 8;28:Article number 18.
    2021-02-24 New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis International Journal of Molecular Sciences. 2021 Feb 24;22(5):Article number 2252.
    2020-10 Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma Neuro-Oncology. 2020 Oct;22(10):1439-1451.
    2020-05-30 Oleic acid -induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis Theranostics. 2020 May 30;10(16):7083-7099.
    2019-10-19 Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets Journal of Biomedical Science. 2019 Oct 19;26:Article number 77.
    2019-09-03 Role of autophagy in therapeutic resistance of glioblastoma Journal of Cancer Metastasis and Treatment. 2019 Sep 3;5:Article number 66.
    2019-06 Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial Head and Neck. 2019 Jun;41(6):1703-1712.
    2017-11 Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19.
    2017-10 Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin FASEB Journal. 2017 Oct;31(10):4265-4276.
    2017-08-12 Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase Redox Biology. 2017 Aug 12;13:655-664.
    2017-05-22 Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma Oncogenesis. 2017 May 22;6(5):Article number e339.
    2017-05 A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531.
    2016-11-18 Suberoylanilide hydroxamic acid represses glioma stem-like cells Journal of Biomedical Science. 2016 Nov 18;23:Article number 81.
    2016-07-19 MicroRNA-17 modulates regulatory T cell function by targeting co-regulators of the foxp3 transcription factor Immunity. 2016 Jul 19;45(1):83-93.
    2015-09 O6-Methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma International Journal of Cancer. 2015 Sep;137(6):1291-1305.
    2015-05 Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin beta1/FAK axis Oncotarget. 2015 May;6(13):11530-11546.
    2015-03 Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer Oral Diseases. 2015 Mar;21(2):207-215.
    2014-12-22 Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation Oncotarget. 2014 Dec 22;6(3):1723-1739.
    2014-11 The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer International Journal of Cancer. 2014 Nov;135(10):2424-2436.
    2014-10-24 Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5year follow-up BMC Cancer. 2014 Oct 24;14:Article number 787.
    2014-08 AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma Tumor Biology. 2014 Aug;35(8):7983-7991.
    2014-07 Cyclin-dependent kinase 4 overexpression is mostly independent of gene amplification and constitutes an independent prognosticator for nasopharyngeal carcinoma Tumor Biology. 2014 Jul;35(7):7209-7216.
    2014-05-05 Tea consumption and risk of head and neck cancer PLoS ONE. 2014 May 5;9(5):Article number e96507.
    2014-02 Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma Tumor Biology. 2014 Feb;35(2):1703-1712.
    2014-01 TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma Tumor Biology. 2014 Jan;35(1):179-187.
    2013-10 Investigating the association between oral hygiene and head and neck cancer Oral Oncology. 2013 Oct;49(10):1010-1017.
    2013-07 Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma Journal of the Formosan Medical Association. 2013 Jul;112(7):382-389.
    2013-06-27 Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance Journal of Biomedical Science. 2013 Jun 27;20(1):Article number 43.
    2013-05 Complete microscale profiling of tumor microangiogenesis: A microradiological methodology reveals fundamental aspects of tumor angiogenesis and yields an array of quantitative parameters for its characterization Biotechnology Advances. 2013 May;31(3):396-401.
    2013-03 Uropathogenic Escherichia coli causes cortical tubular necrotic cell death and the release of macrophage migration inhibitory factor Cytokine. 2013 Mar;61(3):945-952.
    2013-02-01 Allergies and risk of head and neck cancer: An original study plus meta-analysis PLoS ONE. 2013 Feb 1;8(2):Article number e55138.
    2012-07-27 Hepatitis B virus X protein upregulates mTOR signaling through IKKBeta to increase cell proliferation and VEGF production in hepatocellular carcinoma PLoS ONE. 2012 Jul 27;7(7):Article number e41931.
    2011-11-15 Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo Clinical Cancer Research. 2011 Nov 15;17(22):7116-7126.

    显示项目1-50 / 58. (共2页)
    1 2 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈